
European Early-Stage Capital Spreads Across Biotech and AI Deeptech
Fresh rounds from Vienna, Stockholm and a speech-AI player point to deep-tech investor appetite, and platforms built to scale into emerging markets.
AfroEuropa Newsroom
AfroEuropa desk
A cluster of early-stage European deals this week underlines where investors are placing their bets in 2026: precision biology, industrial AI and speech technology built to cross borders. For founders and capital flowing between Europe and Africa, the common thread is platform-based companies designed to scale across multiple markets rather than a single domestic base.
Vienna biotech bets on epigenome editing
Epitome Therapeutics, a Vienna-based spin-off from the European Molecular Biology Laboratory (EMBL), announced €4 million in total funding, EU-Startups reported. The package combines an oversubscribed €2 million pre-seed round with €2 million in non-dilutive grants, co-led by XISTA Science Ventures and Caesar Ventures, with Navec Venture Holding also participating.
Keep reading
Berlin ConTech Startup Kuro Raises €10 Million for AI Aimed at General Contractors
Kuro Technology, founded in 2024, secured €10 million in a round led by UVC Partners to expand its AI software for construction back-office work.
Other highlights
Modder Adds NVIDIA Pascal GPU Support to Windows XP
A modded driver called Forceware 382.69 brings GeForce GTX 10-series cards, including the TITAN Xp, to 32-bit Windows XP.
Follow the storyOne newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.








